We live in an information ecosystem — especially when talking about obesity — that’s full of misinformation, fads and gimmicks, said Ian Patton, director of advocacy and public engagement at Obesity Canada, during a session at Benefits Canada’s 2023 Chronic Disease at Work conference in early February. In the session, supported by Desjardins Insurance, he noted […]
Changes to Ontario’s policy on the use of biosimilars in its public drug plan could result in savings for private benefits plans if they choose to follow the provincial model, says Theresa Tran, a principal in group benefits at Eckler Ltd. Starting March 31, Ontario Drug Benefit recipients who are on an originator biologic will […]
Two-fifths (40 per cent) of U.S. organizations currently offer fertility benefits, up from 30 per cent in 2020, according to a survey by the International Foundation of Employee Benefit Plans. The survey, which examined benchmarking data from more than 500 U.S. employers, also found 28 per cent of respondents said they cover fertility medications, up from […]
Between 2019 and 2021, mental-health drug claims skyrocketed among young Canadians, according to a new report by Sun Life Financial Inc. The report, which identified trends using the insurer’s data, found a 24 per cent increase in drug claims to treat mental-health disorders for people aged 30 and under. On the other hand, drug claims […]
Running for more than 17 years, Benefits Canada‘s Face to Face Drug Plan Management Forum is the industry’s most popular drug benefits conference. In 2022, the event returned to a face-to-face format at the Sheraton Centre in Toronto on Dec. 6. Attendees learned about fresh drug plan design insights, including a new drug launch panel […]
With cost of private drug plan claims rising about 5.5 per cent each year, pooling is one solution that could be beneficial for benefits plan sponsors. “Theoretically, if these claims could be shared across a broader group, such as the complete private insurance industry, plan costs could be less volatile for individual plan sponsors,” said […]
Plan sponsors face challenges balancing benefits plan sustainability while also ensuring their plan members have access to the care they need, said Marie-Hélène Dugal, manager of pharmacy benefit strategy at Medavie Blue Cross, during a session at Benefits Canada’s 2022 Face to Face Drug Plan Management Forum in Toronto in December. Referring to Medavie’s claims data, […]
Attention deficit hyperactivity disorder is commonly misunderstood and can reduce the ability of a person to function while impacting their quality of life, said Anjila Arora, director of pharmaceutical benefits at Sun Life Financial Inc., during a session at Benefits Canada’s 2022 Face to Face Drug Plan Management Forum in Toronto in December. Although ADHD […]
As pharmacists’ scope of practice evolves across the country, their expanded role in drug plan management can improve plan member health and positively impact plan sponsors’ bottom lines. Challenges in the Canadian health-care system — such as the millions of people who don’t have access to a family doctor, extended emergency rooms wait times or […]
With the cost of drug claims continuing to rise in 2021, benefits plan sponsors can enable certain drug programs to curb costs, keeping their plans sustainable and offering the benefits that members highly value, said Lavina Viegas, director of pharmacy operations at Telus Health, during a session at Benefits Canada’s 2022 Face to Face Drug […]